Maximum quantity allowed is 999
Please select the quantity
CAS RN: 140462-76-6 | Product Number: O0361
Olopatadine Hydrochloride
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 1G |
$404.00
|
≥40 | 9 |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | O0361 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__1H__2__3NO__3·HCl = 373.88 |
| Physical State (20 deg.C) | Solid |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 140462-76-6 |
| Related CAS RN | 113806-05-6 |
| Reaxys Registry Number | 6675608 |
| PubChem Substance ID | 87561038 |
| Merck Index (14) | 6840 |
| MDL Number | MFCD00875716 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | 98.0 to 102.0 % |
Properties (reference)
| Melting Point | 248 °C(dec.) |
GHS
Related Laws:
| RTECS# | HQ4135060 |
Transport Information:
| H.S.code* | 2932.99-000 |
Application
Synthesis and antiallergic activity of olopatadine
References
- Synthesis and antiallergic activity of 11-(aminoalkylidene)-6,11-dihydrodibenz[b,e]oxepin derivatives
PubMed Literature
Articles/Brochures
TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.